HCPCS Code Descriptor:
Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion
Route of Administration:
PROVENGE is an Oncology drug manufactured by Dendreon and administered via the Intravenous route of administration. The Q Code: Q2043 is aligned to the drug PROVENGE.